News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

A Promising Target to Treat Asthma, University of Iowa Study


7/25/2013 6:50:43 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

An enzyme known for its role in heart disease may well be a promising target to treat asthma. Researchers from the University of Iowa have found that the enzyme, called CaMKII, is linked to the harmful effects of oxidation in the respiratory tract, triggering asthmatic symptoms. The finding could lead to the development of a drug that would target the CaMKII enzyme, the researchers say.

Hey, check out all the research scientist jobs. Post your resume today!

Read at ScienceDaily
Read at News Release
Read at Zee News
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES